|Penn Genome Frontiers Institute
January 22, 2008, Volume 54, No. 18
Vice Provost for Research Steven J. Fluharty is pleased to announce that the Penn Genome Frontiers Institute (PGFI) will be the new name of the Penn Genomics Institute.
This change reflects the cutting-edge, interdisciplinary work being conducted in genomics research across the University. The Institute will promote research and training in genomics, computational biology, and systems biology, with an emphasis on the interdisciplinary development of new technologies.
“The Genome Frontiers Institute embodies Penn’s commitment to advancing frontiers of knowledge,” said Vice Provost Fluharty. “It uses its research and expertise to help tackle some of the most urgent and exciting scientific challenges around the world.”
The PGFI stands at the forefront of interdisciplinary transformations in biological and biomedical sciences, which aim to develop a comprehensive understanding of biological processes by bringing together such areas as genetics, engineering, molecular biology, evolutionary biology, computer science, and mathematical modeling.
The PGFI pursues this mission with the following aims:
• Lead the development of new genomics technologies;
• Promote genome-scale interdisciplinary research through integrated support of team projects;
• Foster integrated genomics education and training at all levels, from undergraduates to professionals;
• Assist scientists at Penn in leveraging genomic technologies for their research.
The PGFI will be led by Interim Co-Directors James Eberwine (Pharmacology) and Junhyong Kim (Biology), working closely with Associate Directors John Hogenesch (Pharmacology) and Tom Curran (CHOP).